To the Editor In their article on breast cancer risk in BRCA1 mutation carriers who were given hormone replacement therapy postovariectomy, the authors use the word "progesterone" throughout without explanation or qualification. The corresponding author affirmed that most of these women received various progestins, not progesterone.
https://ift.tt/2R2LoPt
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου